FMP
ETFMG Treatments, Testing and Advancements ETF
GERM
AMEX
Inactive Equity
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
19.16 USD
-0.0552 (-0.288%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
AMEX
Description
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
CIK
0001467831
ISIN
US0321085815
CUSIP
N/A
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Jun 18, 2020
Sector Weightings
We are unable to load the chart at this time.
Country Weightings
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
GERM Financial Summary
ISIN
US0321085815
Exchange
AMEX
Beta
1.02
Market Cap
9.59M
52-Week
16.32-20.1994
Volume Avg.
1.2k
Price
19.16
Country
US
Management Assets
-
Total Holdings
-
NAV
-
NAV Currency
-
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest GERM News
It looks like there's no news available.
